Sign In  |  Register  |  About Menlo Park  |  Contact Us

Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast | Traffic

  • Search Hotels in Menlo Park

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Opko Health Inc (NQ: OPK )

1.580 +0.020 (+1.28%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Opko Health Inc

< Previous 1 2 3 4 5 6 Next >
A Preview Of OPKO Health's Earnings
Via Benzinga
MarketBeat Week in Review – 7/17 - 7/21
Investor sentiment remains strong but upcoming tech earnings and an expected interest rate hike may provide more clarity on the short-term outlook for stocks 
Via MarketBeat
Topics Economy
Exposures Economy Interest Rates
OPKO Health is the Little Giant of Diversified Healthcare
Diversified healthcare company OPKO Health Inc. (NASDAQ: OPK) shares may be low priced, but its businesses pipeline of treatments and upside potential may 
Via MarketBeat
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
Why Shares of Opko Health Jumped on Thursday
The FDA approved a growth therapy the company was collaborating on with Pfizer. 
Via The Motley Fool
Why Opko Health Stock Is Moving Today
Opko Health, Inc. 
Via Benzinga
Opko Health (OPK) Q1 2023 Earnings Call Transcript
OPK earnings call for the period ending March 31, 2023. 
Via The Motley Fool
Recap: OPKO Health Q1 Earnings
Via Benzinga
Why OPKO Health Shares Jumped on Wednesday
A major pharma name is showing interest in one of the company's vaccine prospects. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For June 29, 2023
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
FDA Approves Pfizer’s NGENLA™, a Long-Acting Once-Weekly Treatment for Pediatric Growth Hormone Deficiency
From Pfizer Inc.
Via Business Wire
Opko Health (OPK) Q4 2022 Earnings Call Transcript
OPK earnings call for the period ending December 31, 2022. 
Via The Motley Fool
Which Stocks Are Responding To The Strong Jobs Report? 10 Top Movers
The U.S. labor market is sizzling, surpassing all forecasts in May and posting its strongest performance in recent months. 
Via Benzinga
IonQ, Solo Brands And Other Big Stocks Moving Lower In Friday's Pre-Market Session
U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. OPKO Health, Inc. (NASDAQ: OPK) shares dipped 17.4% to $1.47 in... 
Via Benzinga
OPKO Health And 2 Other Penny Stocks Insiders Are Aggressively Buying
The Dow Jones closed lower on Monday after recording sharp gains on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and... 
Via Benzinga
Stocks React To February Jobs Report: The Winners And Losers
The markets have offered investors a rollercoaster ride this week, with a flurry of activity and developments that have sent shockwaves through various sectors. 
Via Benzinga
General Electric, Build-A-Bear Workshop, Asana And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded higher, with the Dow Jones gaining around 50 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Why Miromatrix Medical Shares Are Trading Lower By 40%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Kimball International, Inc. (NASDAQ: KBAL) shares jumped 84.9% to $12.40 after HNI Corporation announced it will acquire the company for $485 million. 
Via Benzinga
Mesoblast, Arlo Technologies, CPI Card Group And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded mixed, with the Nasdaq Composite gaining around 30 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
OPKO Health's Cancer & Infectious Disease Focused Subsidiary Inks Vaccine Development Pact With Merck
Via Benzinga
Union Pacific, Kosmos Energy, Fisker And Other Big Stocks Moving Higher On Monday
U.S. stocks traded higher, with the Dow Jones gaining more than 300 points on Monday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
5 Most Cheapest Stocks In The Healthcare Sector: Bio-Techne, Mirati Therapeutics And More
The most oversold stocks in the healthcare sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
Earnings Scheduled For February 23, 2023
Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter. 
Via Benzinga
Why Hoth Therapeutics Shares Are Trading Higher By More Than 130%? Here Are 60 Stocks Moving In Thursday's Mid-Day Session
Gainers Hoth Therapeutics, Inc. (NASDAQ: HOTH) shares jumped 131.5% to $10.19 after the FDA accepted the IND application for HT-001. 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
  Monday saw 196 companies set new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 298 companies achieved new lows for the year. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2022
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
  On Monday, 79 companies reached new 52-week lows. 
Via Benzinga
OPKO Health, electroCore And This Penny Stock Insiders Are Aggressively Buying
The Dow Jones jumped by over 1,200 points on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern... 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MenloPark.com & California Media Partners, LLC. All rights reserved.